Surgical Innovations Statistics
Want to see GB:SUN full AI Analyst Report?
Surgical Innovations (SUN) Stock Statistics & Valuation Metrics
Total Valuation
Surgical Innovations has a market cap or net worth of GBX 3.73M. The enterprise value is GBX 4.66M.
- Market Cap
- GBX 3.73M
- Enterprise Value
- GBX 4.66M
Share Statistics
Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 932,816,160
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Surgical Innovations’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -8.08%.
- Return on Equity (ROE)
- -0.12
- Return on Assets (ROA)
- -0.08
- Return on Invested Capital (ROIC)
- -8.08%
- Return on Capital Employed (ROCE)
- -0.09
- Revenue Per Employee
- 124.75K
- Profits Per Employee
- -9,623.656
- Employee Count
- 93
- Asset Turnover
- 1.00
- Inventory Turnover
- 3.90
Valuation Ratios
The current PE Ratio of Surgical Innovations is -4.00. Surgical Innovations’s PEG ratio is -0.11.
- PE Ratio
- -4.00
- PS Ratio
- 0.33
- PB Ratio
- 0.50
- Price to FCF
- 3.85
- Price to Operating Cash Flow
- 3.70
- PEG Ratio
- -0.11
Income Statement
In the last 12 months, Surgical Innovations had revenue of 11.60M and earned -895.00K in profits. Earnings per share was -0.00.
- Revenue
- 11.60M
- Gross Profit
- 3.05M
- Operating Income
- -731.00K
- Pretax Income
- -944.00K
- Net Income
- -895.00K
- EBITDA
- -73.00K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was 1.01M and capital expenditures -40,000, giving a free cash flow of 968.00K billion.
- Operating Cash Flow
- 1.01M
- Free Cash Flow
- 968.00K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 25.94%
- Earnings Yield
- -31.20%
Stock Price Statistics
- Beta
- 0.20
- 52-Week Price Change
- -30.43%
- 50-Day Moving Average
- 0.40
- 200-Day Moving Average
- 0.45
- Relative Strength Index (RSI)
- 57.19
- Average Volume (3m)
- 1.01M
Important Dates
Surgical Innovations upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 30, 2026
- Next Earnings Date
- Mar 25, 2027
- Ex-Dividend Date
- ―
Financial Position
Surgical Innovations as a current ratio of 1.48, with Debt / Equity ratio of 8.70%
- Current Ratio
- 1.48
- Quick Ratio
- 0.85
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 2.03
- Interest Coverage Ratio
- -11.08
Taxes
In the past 12 months, Surgical Innovations has paid -49.00K in taxes.
- Income Tax
- -49.00K
- Effective Tax Rate
- 0.05
Enterprise Valuation
Surgical Innovations EV to EBITDA ratio is -9.65, with an EV/FCF ratio of 4.09.
- EV to Sales
- 0.34
- EV to EBITDA
- -9.65
- EV to Free Cash Flow
- 4.09
- EV to Operating Cash Flow
- 3.93
Balance Sheet
Surgical Innovations has GBX 361.00K in cash and marketable securities with GBX 587.00K in debt, giving a net cash position of -GBX 226.00K billion.
- Cash & Marketable Securities
- GBX 361.00K
- Total Debt
- GBX 587.00K
- Net Cash
- -GBX 226.00K
- Net Cash Per Share
- GBX 0.00
- Tangible Book Value Per Share
- GBX 0.00
Margins
Gross margin is 25.10%, with operating margin of -8.88%, and net profit margin of -10.14%.
- Gross Margin
- 25.10%
- Operating Margin
- -8.88%
- Pretax Margin
- -10.57%
- Net Profit Margin
- -10.14%
- EBITDA Margin
- -3.57%
- EBIT Margin
- -8.88%
Analyst Forecast
The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -3.68%
- EPS Growth Forecast
- 20.00%
Scores
- Smart Score
- ―
- AI Score
- 47
